📊 Score Breakdown
Offering Ability
100
Cash Runway
95
Float Risk
30
Warrant Exposure
90
Convertible Debt—
🌦️ Dilution Forecast
🌩️
Severe
Multiple high-probability dilution events detected
75%
💰 Capital Raise
93%
• Critical: only 2.4 months cash remaining
• Active shelf registration ($50M, 2339% of market cap)
📜 Warrant Exercise
60%
• Massive warrant overhang: 175% of shares outstanding
• Warrant risk score very high (90/100)
📉 Score Deterioration
55%
• Score rose 69 points recently (worsening)
• Score already CRITICAL (89/100) — events likely imminent
💹 Market Data
Market Cap$2.14M
Shares Outstanding700.8K
Float695.9K
Cash$796.0K
Debt$16.69M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 164.3% shares (2025Q4 vs prior)
14 institutional holders · 829.2K shares
#1
UBS Group AG
304.1K shares
#2
SUSQUEHANNA INTERNATIONAL GROUP, LLP
286.9K shares
#3
FLOW TRADERS U.S. LLC
66.9K shares
+ 11 more holders Sign up free to view →
📉 Short Interest
Short Interest215.1K
Days to Cover1.0
% of Float30.9%
FINRA data as of Apr 30, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Dec 31, 2025
xbrl
XBRL WARRANT
Oct 30, 2023
S-1
SHELF
Apr 29, 2026
8-K
8K EVENT
Apr 28, 2026
EFFECT
EFFECT
Feb 11, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for DRCT
📊 DRCT FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 DRCT Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.